Form 8-K - Current report:
SEC Accession No. 0001104659-20-088407
Filing Date
2020-07-30
Accepted
2020-07-30 19:13:22
Documents
12
Period of Report
2020-07-30
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2026191d1_8k.htm   iXBRL 8-K 24411
  Complete submission text file 0001104659-20-088407.txt   196387

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA fold-20200730.xsd EX-101.SCH 3216
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20200730_lab.xml EX-101.LAB 34591
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20200730_pre.xml EX-101.PRE 22730
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2026191d1_8k_htm.xml XML 3483
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 201061824
SIC: 2834 Pharmaceutical Preparations